WebMULTAQ is contraindicated in patients in atrial fibrillation (AF) who will not or cannot be cardioverted into normal sinus rhythm [see Contraindications (4), Warnings and … Web10 iun. 2024 · Common Multaq side effects may include: stomach pain, indigestion, nausea, vomiting, diarrhea; feeling weak or tired; or skin rash, itching, or redness. This is not a …
MULTAQ Dosage & Rx Info Uses, Side Effects - Renal and …
WebMonitor renal function periodically. Small increases in creatinine levels (about 0.1 mg/dL) following MULTAQ treatment initiation have been shown to be a result of inhibition of creatinine’s tubular secretion. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Web21 mai 2024 · Multaq 400mg film-coated tablets - Summary of Product Characteristics (SmPC) by SANOFI ... 4.3 Contraindications • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 ... 4.4 … stove top pepper steak
HIGHLIGHTS OF PRESCRIBING INFORMATION MULTAQ ...
WebMULTAQ 400 mg tablets are provided as white film-coated tablets for oral administration, oblong-shaped, engraved with a double wave marking on one side and “4142” code on … Web23 mai 2024 · Contraindications Permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored). Symptomatic heart failure with NYHA class IV symptoms or recent decompensation requiring hospitalization. Second- or third-degree AV block or sick sinus syndrome (except in patients with a functioning pacemaker). Web4 CONTRAINDICATIONS MULTAQ is contraindicated in patients with: • Permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored) [see Boxed Warning, Warnings and Precautions (5.2)] • Symptomatic heart failure with recent decompensation requiring hospitalization or NYHAClass IV rotary sbc